These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 30571411)
1. Increased Use of Ticagrelor After Myocardial Infarction Is Not Associated With Intracranial Hemorrhage. Graipe A; Söderström L; Mooe T Stroke; 2018 Dec; 49(12):2877-2882. PubMed ID: 30571411 [TBL] [Abstract][Full Text] [Related]
2. Ischemic stroke rates decrease with increased ticagrelor use after acute myocardial infarction in patients treated with percutaneous coronary intervention. Ulvenstam A; Henriksson R; Söderström L; Mooe T Eur J Prev Cardiol; 2018 Jul; 25(11):1219-1230. PubMed ID: 29929389 [TBL] [Abstract][Full Text] [Related]
3. Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction. Henriksson R; Ulvenstam A; Söderström L; Mooe T BMC Cardiovasc Disord; 2019 Mar; 19(1):51. PubMed ID: 30832574 [TBL] [Abstract][Full Text] [Related]
4. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health. Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK; J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138 [TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk. Park KH; Jeong MH; Kim HK; Ki YJ; Kim SS; Choi DH; Koh YY; Ahn Y; Kim HS; Gwon HC; Rha SW; Hwang JY; J Korean Med Sci; 2021 Nov; 36(42):e268. PubMed ID: 34725976 [TBL] [Abstract][Full Text] [Related]
6. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease. Bansilal S; Bonaca MP; Cornel JH; Storey RF; Bhatt DL; Steg PG; Im K; Murphy SA; Angiolillo DJ; Kiss RG; Parkhomenko AN; Lopez-Sendon J; Isaza D; Goudev A; Kontny F; Held P; Jensen EC; Braunwald E; Sabatine MS; Oude Ophuis AJ J Am Coll Cardiol; 2018 Feb; 71(5):489-496. PubMed ID: 29406853 [TBL] [Abstract][Full Text] [Related]
7. Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Aradi D; Komócsi A; Vorobcsuk A; Serebruany VL Thromb Haemost; 2013 Jan; 109(1):93-101. PubMed ID: 23197191 [TBL] [Abstract][Full Text] [Related]
8. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial. Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and Bleeding Risks in Acute Myocardial Infarction Newly Treated With Ticagrelor vs. Clopidogrel in Taiwan. Lee CH; Cheng CL; Kao Yang YH; Chao TH; Chen JY; Li YH Circ J; 2018 Feb; 82(3):747-756. PubMed ID: 29081474 [TBL] [Abstract][Full Text] [Related]
10. Long-term use of ticagrelor in patients with prior myocardial infarction. Bonaca MP; Bhatt DL; Cohen M; Steg PG; Storey RF; Jensen EC; Magnani G; Bansilal S; Fish MP; Im K; Bengtsson O; Oude Ophuis T; Budaj A; Theroux P; Ruda M; Hamm C; Goto S; Spinar J; Nicolau JC; Kiss RG; Murphy SA; Wiviott SD; Held P; Braunwald E; Sabatine MS; N Engl J Med; 2015 May; 372(19):1791-800. PubMed ID: 25773268 [TBL] [Abstract][Full Text] [Related]
11. Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry. Völz S; Petursson P; Odenstedt J; Ioanes D; Haraldsson I; Angerås O; Dworeck C; Hirlekar G; Myredal A; Albertsson P; Råmunddal T; Redfors B; Omerovic E J Am Heart Assoc; 2020 Jul; 9(14):e015990. PubMed ID: 32662350 [TBL] [Abstract][Full Text] [Related]
12. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54). Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775 [TBL] [Abstract][Full Text] [Related]
14. Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function. Edfors R; Sahlén A; Szummer K; Renlund H; Evans M; Carrero JJ; Spaak J; James SK; Lagerqvist B; Varenhorst C; Jernberg T Heart; 2018 Oct; 104(19):1575-1582. PubMed ID: 29574413 [TBL] [Abstract][Full Text] [Related]
15. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638 [TBL] [Abstract][Full Text] [Related]
16. Outcomes after ticagrelor versus clopidogrel treatment in end-stage renal disease patients with acute myocardial infarction: a nationwide cohort study. Tung YC; Chang CJ; Liu JR; Chang SH; Chan YH; Kuo CT; See LC Sci Rep; 2021 Oct; 11(1):20826. PubMed ID: 34675293 [TBL] [Abstract][Full Text] [Related]
17. Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Åkerblom A; Wojdyla DM; Wallentin L; James SK; de Souza Brito F; Steg PG; Cannon CP; Katus HA; Himmelmann A; Storey RF; Becker RC; Lopes RD; Am Heart J; 2019 Jul; 213():57-65. PubMed ID: 31108273 [TBL] [Abstract][Full Text] [Related]
18. Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial. Brilakis ES; Held C; Meier B; Cools F; Claeys MJ; Cornel JH; Aylward P; Lewis BS; Weaver D; Brandrup-Wognsen G; Stevens SR; Himmelmann A; Wallentin L; James SK Am Heart J; 2013 Sep; 166(3):474-80. PubMed ID: 24016496 [TBL] [Abstract][Full Text] [Related]
19. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Ticagrelor vs. Clopidogrel in East Asian Patients with Acute Myocardial Infarction: A Nationwide Cohort Study. Chang CJ; Tung YC; Liu JR; Chang SH; Kuo CT; See LC Clin Pharmacol Ther; 2021 Feb; 109(2):443-451. PubMed ID: 32767756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]